Pharmacokinetics interaction studies between rifampicin and protease inhibitors: methodological problems.
Toibaro
Javier J
JJ
Losso
Marcelo H
MH
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy; D000904:Antibiotics, Antitubercular / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury; D004347:Drug Interactions; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D006801:Humans; D012107:Research Design; D012293:Rifampin / Q000009:adverse effects*; D014376:Tuberculosis / Q000188:drug therapy
D000904:Antibiotics, Antitubercular; D017320:HIV Protease Inhibitors; D012293:Rifampin